Lotus Eye Hospital And Institute Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
- Paid Up Capital ₹ 20.80 Cr
- Company Age 27 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 17.43 Cr
- Revenue Growth 21.09%
- Profit Growth 36.63%
- Ebitda 29.75%
- Net Worth 5.44%
- Total Assets 2.58%
About Lotus Eye Hospital And Institute
Lotus Eye Hospital And Institute Limited (LEHAIL) is a leading Public Limited Indian Non-Government Company incorporated in India on 14 March 1997 and has a history of 27 years and 11 months. Its registered office is in Coimbatore, Tamil Nadu, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 532998 and on the National Stock Exchange(NSE) under LOTUSEYE.
The Corporate was formerly known as Kalaivani Health Centre Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 20.80 Cr.
The company has closed loans amounting to ₹17.43 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Lotus Eye Hospital And Institute Limited India are Ramanujam Reghunathan as Cfo, Kuttapalayam Songappan as Ceo, and Achuth Menon as Company Secretary. Kaarthikeyan Ramasamy, Kuttapalayam Songappan, Sundaramoorthy Sangeetha, and Six other members serve as directors at the Company.
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
Industry
What products or services does Lotus Eye Hospital And Institute Limited offer?
Lotus Eye Hospital And Institute Limited offers a wide range of products and services, including Medical Surgery & Treatment Centres, Eye Treatment, Medical Treatment Services.
Who are the key members and board of directors at Lotus Eye Hospital And Institute?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sundaramoorthy Sangeetha  | Managing Director | 14-Mar-2006 | Current |
| Ramanujam Reghunathan | CFO | 25-May-2022 | Current |
| Kuttapalayam Songappan | CEO | 05-Aug-2020 | Current |
| Achuth Menon | Company Secretary | 15-Feb-2022 | Current |
Board Members (8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gopalakrishnan Veeramani | Director | 21-Dec-2022 | Current |
| Kaarthikeyan Ramasamy | Director | 16-Oct-2007 | Current |
| Kuttapalayam Songappan | Whole-Time Director | 10-Feb-2021 | Current |
| Yogesh Shah | Director | 16-Oct-2007 | Current |
| Sundaramoorthy Kavetha | Director | 14-Mar-1997 | Current |
| Marappa Alagiriswamy | Director | 28-May-2012 | Current |
Financial Performance of Lotus Eye Hospital And Institute.
Lotus Eye Hospital And Institute Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.09% increase. The company also saw a substantial improvement in profitability, with a 36.63% increase in profit. The company's net worth moved up by a moderate rise of 5.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lotus Eye Hospital And Institute?
In 2023, Lotus Eye Hospital And Institute had a promoter holding of 58.17% and a public holding of 41.83%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hoglund Marine Solutions Private LimitedPerumalswamy Mahendran is a mutual person
Roots Auto Products Private LimitedKaarthikeyan Ramasamy is a mutual person
Elysium Constructions Private LimitedGopalakrishnan Veeramani is a mutual person
Elysium Real Properties Private LimitedGopalakrishnan Veeramani is a mutual person
Elysium Properties India Private LimitedGopalakrishnan Veeramani is a mutual person
Life Positive Private LimitedKaarthikeyan Ramasamy is a mutual person
Charges (Loans)
₹0
₹17.43 Cr
Charges Breakdown by Lending Institutions
- Icici Bank Limited : 10.00 Cr
- Bausch & Lomb Eyecare (India) Pvt. Ltd. : 1.90 Cr
- Hdfc Bank Limited : 1.67 Cr
- Abn Amro Bank Nv : 1.18 Cr
- Indian Overseas Bank : 1.16 Cr
- Others : 1.53 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Sep 2014 | Hdfc Bank Limited | ₹8.50 M | Satisfied |
| 03 Feb 2014 | Canara Bank | ₹0.68 M | Satisfied |
| 08 Aug 2008 | Citicorp Finance (India) Limited | ₹3.08 M | Satisfied |
| 28 May 2008 | Citicorp Finance (I) Limited | ₹1.15 Cr | Satisfied |
| 02 Nov 2007 | Abn Amro Bank Nv | ₹1.18 Cr | Satisfied |
How Many Employees Work at Lotus Eye Hospital And Institute?
Lotus Eye Hospital And Institute has a workforce of 317 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lotus Eye Hospital And Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lotus Eye Hospital And Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
